MYC through miR-17-92 Suppresses Specific Target Genes to Maintain Survival, Autonomous Proliferation, and a Neoplastic State
Permanent link to this recordhttp://hdl.handle.net/10754/598926
MetadataShow full item record
AbstractThe MYC oncogene regulates gene expression through multiple mechanisms, and its overexpression culminates in tumorigenesis. MYC inactivation reverses turmorigenesis through the loss of distinguishing features of cancer, including autonomous proliferation and survival. Here we report that MYC via miR-17-92 maintains a neoplastic state through the suppression of chromatin regulatory genes Sin3b, Hbp1, Suv420h1, and Btg1, as well as the apoptosis regulator Bim. The enforced expression of miR-17-92 prevents MYC suppression from inducing proliferative arrest, senescence, and apoptosis and abrogates sustained tumor regression. Knockdown of the five miR-17-92 target genes blocks senescence and apoptosis while it modestly delays proliferative arrest, thus partially recapitulating miR-17-92 function. We conclude that MYC, via miR-17-92, maintains a neoplastic state by suppressing specific target genes.
CitationLi Y, Choi PS, Casey SC, Dill DL, Felsher DW (2014) MYC through miR-17-92 Suppresses Specific Target Genes to Maintain Survival, Autonomous Proliferation, and a Neoplastic State. Cancer Cell 26: 262–272. Available: http://dx.doi.org/10.1016/j.ccr.2014.06.014.
SponsorsWe thank members of the Felsher Laboratory for generously providing their suggestions and thoughtful discussions. This work was supported by the NIH R01CA170378 (D.W.F.), U54CA149145 (D.W.F. and D.L.D.), U54CA143907 (D.W.F. and Y.L.), and 1F32CA177139 and 5T32A107290 (S.C.C.) grants; the Leukemia and Lymphoma Society Translational Research grant R6223-07 (D.W.F.); and a King Abdullah University of Science and Technology research grant (D.L.D.).
PubMed Central IDPMC4191901
CollectionsPublications Acknowledging KAUST Support
- TSA suppresses miR-106b-93-25 cluster expression through downregulation of MYC and inhibits proliferation and induces apoptosis in human EMC.
- Authors: Zhao ZN, Bai JX, Zhou Q, Yan B, Qin WW, Jia LT, Meng YL, Jin BQ, Yao LB, Wang T, Yang AG
- Issue date: 2012
- miR-34a increases cisplatin sensitivity of osteosarcoma cells in vitro through up-regulation of c-Myc and Bim signal.
- Authors: Li QC, Xu H, Wang X, Wang T, Wu J
- Issue date: 2017 Dec 12
- miR-17-92 cluster microRNAs confers tumorigenicity in multiple myeloma.
- Authors: Chen L, Li C, Zhang R, Gao X, Qu X, Zhao M, Qiao C, Xu J, Li J
- Issue date: 2011 Oct 1
- miR-451 suppresses bladder cancer cell migration and invasion via directly targeting c-Myc.
- Authors: Wang J, Zhao X, Shi J, Pan Y, Chen Q, Leng P, Wang Y
- Issue date: 2016 Oct
- RUNX3 is down-regulated in glioma by Myc-regulated miR-4295.
- Authors: Li X, Zheng J, Diao H, Liu Y
- Issue date: 2016 Mar